Diagnostic performance of circular RNAs in human cancers: A systematic review and meta-analysis
- PMID: 31106993
- PMCID: PMC6625099
- DOI: 10.1002/mgg3.749
Diagnostic performance of circular RNAs in human cancers: A systematic review and meta-analysis
Abstract
Background: Recently, accumulating evidence have revealed that circular RNA (circRNA) was deregulated in multiple types of cancer, suggesting that circRNA might serve as a novel candidate biomarker of cancer diagnosis. However, inconsistent results have become an obstacle in applying circRNAs to clinical practice. The aim of this study is to evaluate diagnostic value of circRNAs among cancers.
Methods: A literature search was systematically performed among PubMed, Sciencedirect, Cochrane Library, Web of Science, Wanfang, and Chinese National Knowledge Infrastructure databases up to February 15, 2019. The pooled sensitivity (SEN), specificity (SPE), positive likelihood ratios, negative likelihood ratios, diagnostic odds ratio, and area under the SROC curve (AUC) were applied to evaluate diagnostic performance of circRNAs.
Results: In total, the study included 64 studies with single circRNA and 13 studies with combined circRNAs. Overall, the study presented that a single circRNA had moderate diagnostic value, with a SEN of 0.75, a SPE of 0.76, and an AUC of 0.82. The plasma circRNAs had higher diagnostic accuracy than tissue (AUC: 0.87, 95% confidence interval [CI]: 0.83-0.89 for plasma/serum subgroup; AUC: 0.79, 95% CI: 0.75-0.82 for tissue subgroup). Furthermore, the combined circRNAs had good diagnostic efficacy for GC, with a SEN of 0.89, a SPE of 0.94, and an AUC of 0.97, respectively.
Conclusion: This study confirmed that circRNAs may be candidate biomarkers for cancer diagnosis. In particular, diagnosis of combined circRNAs will be a new alternative applied to clinical research and practice for cancer.
Keywords: CircRNA; biomarker; cancer; diagnosis.
© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
Conflict of interest statement
No conflicts of interest proclaimed.
Figures





Similar articles
-
Accuracy Evaluation of Circular RNA in Diagnosing Lung Cancer in a Chinese Population.Dis Markers. 2019 Oct 20;2019:7485389. doi: 10.1155/2019/7485389. eCollection 2019. Dis Markers. 2019. PMID: 31781305 Free PMC article. Review.
-
Diagnostic value of circular RNAs in colorectal cancer: A systematic review and meta-analysis.Pathol Res Pract. 2019 Dec;215(12):152680. doi: 10.1016/j.prp.2019.152680. Epub 2019 Oct 3. Pathol Res Pract. 2019. PMID: 31635986
-
CircRNAs as promising biomarker in diagnosis of breast cancer: An updated meta-analysis.J Clin Lab Anal. 2021 Sep;35(9):e23934. doi: 10.1002/jcla.23934. Epub 2021 Jul 31. J Clin Lab Anal. 2021. PMID: 34331339 Free PMC article.
-
Circular RNAs as diagnostic biomarkers in gastric cancer: A meta-analysis review.Pathol Res Pract. 2019 Jun;215(6):152419. doi: 10.1016/j.prp.2019.04.011. Epub 2019 Apr 17. Pathol Res Pract. 2019. PMID: 31043351 Review.
-
Systematic Review and Meta-Analysis of the Utility of Circular RNAs as Biomarkers of Hepatocellular Carcinoma.Can J Gastroenterol Hepatol. 2019 May 2;2019:1684039. doi: 10.1155/2019/1684039. eCollection 2019. Can J Gastroenterol Hepatol. 2019. PMID: 31187026 Free PMC article.
Cited by
-
Circular RNA circ-LRP6 facilitates Myc-driven tumorigenesis in esophageal squamous cell cancer.Bioengineered. 2020 Dec;11(1):932-938. doi: 10.1080/21655979.2020.1809922. Bioengineered. 2020. PMID: 32867570 Free PMC article.
-
Circular RNA in cancer development and immune regulation.J Cell Mol Med. 2022 Mar;26(6):1785-1798. doi: 10.1111/jcmm.16102. Epub 2020 Dec 5. J Cell Mol Med. 2022. PMID: 33277969 Free PMC article. Review.
-
Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies.Cancers (Basel). 2019 Aug 14;11(8):1170. doi: 10.3390/cancers11081170. Cancers (Basel). 2019. PMID: 31416190 Free PMC article. Review.
-
Circular RNAs are Potential Prognostic Markers of Head and Neck Squamous Cell Carcinoma: Findings of a Meta-Analysis Study.Front Oncol. 2022 Feb 28;12:782439. doi: 10.3389/fonc.2022.782439. eCollection 2022. Front Oncol. 2022. PMID: 35296016 Free PMC article.
-
Circular RNAs in gastrointestinal cancer: Current knowledge, biomarkers and targeted therapy (Review).Int J Mol Med. 2020 Nov;46(5):1611-1632. doi: 10.3892/ijmm.2020.4731. Epub 2020 Sep 16. Int J Mol Med. 2020. PMID: 33000182 Free PMC article. Review.
References
-
- Chen, D. , Zhang, C. , Lin, J. , Song, X. , & Wang, H. (2018). Screening differential circular RNA expression profiles reveal that hsa_circ_0128298 is a biomarker in the diagnosis and prognosis of hepatocellular carcinoma. Cancer Management and Research, 10, 1275–1283. 10.2147/cmar.s166740 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous